- Home
- WIA vs INFU Comparison
WIA vs INFU Comparison
Compare WIA & INFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WIA
- INFU
- Stock Information
- Founded
- WIA 2003
- INFU 2005
- Country
- WIA United States
- INFU United States
- Employees
- WIA N/A
- INFU N/A
- Industry
- WIA Trusts Except Educational Religious and Charitable
- INFU Medical/Dental Instruments
- Sector
- WIA Finance
- INFU Health Care
- Exchange
- WIA Nasdaq
- INFU Nasdaq
- Market Cap
- WIA 186.8M
- INFU 189.2M
- IPO Year
- WIA N/A
- INFU N/A
- Fundamental
- Price
- WIA $8.17
- INFU $7.98
- Analyst Decision
- WIA
- INFU
- Analyst Count
- WIA 0
- INFU 0
- Target Price
- WIA N/A
- INFU N/A
- AVG Volume (30 Days)
- WIA 39.2K
- INFU 65.5K
- Earning Date
- WIA 01-01-0001
- INFU 03-13-2025
- Dividend Yield
- WIA 12.29%
- INFU N/A
- EPS Growth
- WIA N/A
- INFU 60.96
- EPS
- WIA N/A
- INFU 0.07
- Revenue
- WIA N/A
- INFU $132,783,999.00
- Revenue This Year
- WIA N/A
- INFU $10.23
- Revenue Next Year
- WIA N/A
- INFU $8.80
- P/E Ratio
- WIA N/A
- INFU $114.28
- Revenue Growth
- WIA N/A
- INFU 8.17
- 52 Week Low
- WIA $7.56
- INFU $5.74
- 52 Week High
- WIA $8.91
- INFU $10.03
- Technical
- Relative Strength Index (RSI)
- WIA 60.55
- INFU 45.87
- Support Level
- WIA $7.94
- INFU $7.42
- Resistance Level
- WIA $8.16
- INFU $8.15
- Average True Range (ATR)
- WIA 0.07
- INFU 0.35
- MACD
- WIA 0.03
- INFU -0.01
- Stochastic Oscillator
- WIA 96.00
- INFU 40.58
About WIA Western Asset Inflation-Linked Income Fund
Western Asset Inflation Linked Income Fund is a diversified, closed-end management investment company. The primary investment objective of the group is to provide current income while its secondary investment objective is capital appreciation.
About INFU InfuSystems Holdings Inc.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The first platform is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second platform, Device Solutions, supports the Patient Services platform and leverages strong service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair.